Eroding Judicial Deference to the FDA — Consequences for Public Health

The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2023-03, Vol.388 (11), p.963-966
Hauptverfasser:	Daval, C. Joseph Ross, Bendicksen, Liam, Kesselheim, Aaron S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aggressiveness and the FDA Bans Brand names Coal-fired power plants Coronaviruses COVID-19 Devices Drugs Generic drugs Government Regulation Health Law Health Policy Humans Medical device industry Medical equipment Patient safety Prescription drugs Public Health Public Health - legislation & jurisprudence Public Health General Regulatory agencies Smoking cessation Tobacco United States United States Food and Drug Administration - legislation & jurisprudence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMp2215193